IL103040A0 - Heterocyclically substituted quinolylmethoxy-phenylacetamides,their preparation and pharmaceutical compositions containing them - Google Patents

Heterocyclically substituted quinolylmethoxy-phenylacetamides,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL103040A0
IL103040A0 IL103040A IL10304092A IL103040A0 IL 103040 A0 IL103040 A0 IL 103040A0 IL 103040 A IL103040 A IL 103040A IL 10304092 A IL10304092 A IL 10304092A IL 103040 A0 IL103040 A0 IL 103040A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
phenylacetamides
preparation
compositions containing
heterocyclically substituted
Prior art date
Application number
IL103040A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL103040A0 publication Critical patent/IL103040A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
IL103040A 1991-09-06 1992-09-03 Heterocyclically substituted quinolylmethoxy-phenylacetamides,their preparation and pharmaceutical compositions containing them IL103040A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4129742A DE4129742A1 (de) 1991-09-06 1991-09-06 Heterocyclisch substituierte chinolylmethoxy-phenylacetamide

Publications (1)

Publication Number Publication Date
IL103040A0 true IL103040A0 (en) 1993-02-21

Family

ID=6440067

Family Applications (1)

Application Number Title Priority Date Filing Date
IL103040A IL103040A0 (en) 1991-09-06 1992-09-03 Heterocyclically substituted quinolylmethoxy-phenylacetamides,their preparation and pharmaceutical compositions containing them

Country Status (19)

Country Link
US (1) US5266578A (hu)
EP (1) EP0530639B1 (hu)
JP (1) JPH05194403A (hu)
KR (1) KR930006004A (hu)
CN (1) CN1070190A (hu)
AT (1) ATE110070T1 (hu)
AU (1) AU649351B2 (hu)
CA (1) CA2077465A1 (hu)
CZ (1) CZ276092A3 (hu)
DE (2) DE4129742A1 (hu)
DK (1) DK0530639T3 (hu)
ES (1) ES2057953T3 (hu)
FI (1) FI923968A (hu)
HU (1) HUT65660A (hu)
IL (1) IL103040A0 (hu)
MX (1) MX9204913A (hu)
NO (1) NO923181L (hu)
NZ (1) NZ244225A (hu)
TW (1) TW221431B (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4219765A1 (de) * 1992-06-17 1993-12-23 Bayer Ag Substituierte (Benzothiazolyl- und Chinoxalyl-methoxy)phenylessigsäurederivate
ES2062943B1 (es) * 1993-03-23 1995-11-16 Uriach & Cia Sa J Nuevos derivados de la (2-metil-3-piridil) cianometilpiperazinas.
EP0634169B1 (en) * 1993-06-29 2000-01-05 Takeda Chemical Industries, Ltd. Quinoline or quinazoline derivatives and their use in the manufacture of a medicament for the treatment of osteoporosis
ES2103180B1 (es) * 1994-08-01 1998-04-01 Menarini Lab Fenilacetamidas con accion antagonista de los leucotrienos.
DE4443892A1 (de) * 1994-12-09 1996-06-13 Bayer Ag 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate
EP0725063A1 (de) * 1995-02-01 1996-08-07 Ciba-Geigy Ag Chinolin-Derivate
US6121300A (en) * 1998-11-10 2000-09-19 Wagle; Dilip R. Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts
US6399641B1 (en) * 2000-07-13 2002-06-04 Hoffmann-La Roche Inc. 2H-tetrazole-amide compounds with therapeutic activity as metabotropic glutamate receptor agonists
CN1898221A (zh) * 2003-09-06 2007-01-17 沃泰克斯药物股份有限公司 Atp-结合弹夹转运蛋白的调控剂
KR102393675B1 (ko) * 2021-08-20 2022-05-11 (주)삼우공간건축사사무소 공동주택용 세대현관의 안전바닥패널

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987005510A1 (en) * 1986-03-13 1987-09-24 Rorer International (Overseas) Inc. Quinolinyl ether or thioether tetrazoles as agents for the treatment of hypersensitive ailments
DE3900261A1 (de) * 1988-05-31 1989-12-07 Bayer Ag Substituierte 4-(chinolin-2-yl-methoxy) phenyl-essigsaeure-derivate
US5102881A (en) * 1988-06-27 1992-04-07 Merck Frosst Canada, Inc. Quinoline ether alkanoic acids
DE3916663A1 (de) * 1989-05-23 1990-11-29 Bayer Ag Substituierte (chinolin-2-yl-methoxy)phenyl-acyl-sulfonamide und -cyanamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US5041453A (en) * 1990-05-30 1991-08-20 Rhone-Poulenc Rorer Pharmaceuticals Inc. Quinolinyl-benzoheterobicyclic derivatives as antagonists of leukotriene D4

Also Published As

Publication number Publication date
ATE110070T1 (de) 1994-09-15
HUT65660A (en) 1994-07-28
EP0530639A1 (de) 1993-03-10
CN1070190A (zh) 1993-03-24
TW221431B (hu) 1994-03-01
JPH05194403A (ja) 1993-08-03
CZ276092A3 (en) 1993-06-16
DE59200387D1 (de) 1994-09-22
KR930006004A (ko) 1993-04-20
FI923968A (fi) 1993-03-07
DE4129742A1 (de) 1993-03-11
CA2077465A1 (en) 1993-03-07
AU649351B2 (en) 1994-05-19
FI923968A0 (fi) 1992-09-04
HU9202850D0 (en) 1992-11-30
NO923181L (no) 1993-03-08
DK0530639T3 (da) 1994-12-05
AU2205492A (en) 1993-03-11
MX9204913A (es) 1993-03-01
NZ244225A (en) 1994-08-26
US5266578A (en) 1993-11-30
NO923181D0 (no) 1992-08-14
ES2057953T3 (es) 1994-10-16
EP0530639B1 (de) 1994-08-17

Similar Documents

Publication Publication Date Title
NZ216657A (en) N-buten-3-yl-azaheterocyclic carboxylic acid compounds and pharmaceutical compositions
IL108436A0 (en) Five-membered heterocycles, their preparation and pharmaceutical compositions containing them
MY104685A (en) Substituted thiazoles and their use as fungicides.
GR3018541T3 (en) Condensed heterocyclic compounds and their use in therapy.
IL64885A (en) 3,20-dioxo-1,4-pregnadiene-17alpha-ol-17-aromatic heterocyclic esters,their preparation and pharmaceutical compositions containing them
AU639611B2 (en) Saturated hydroxyalkylquinoline acids as leukotriene antagonists
PT79840A (en) Process for the preparation of polipeptides with alpha-amilase inhibiting action and pharmaceutical compositions therewith
IL103040A0 (en) Heterocyclically substituted quinolylmethoxy-phenylacetamides,their preparation and pharmaceutical compositions containing them
HU9501799D0 (en) Substituted triols
DK0435333T3 (da) Cephalosporinderivater, fremgangsmåde til fremstilling deraf og antimikrobielt præparat indeholdende derivaterne
IL81179A (en) N-phenylbutenyl substituted azaheterocyclic carboxylic acids,their preparation and pharmaceutical compositions comprising them
AU542902B2 (en) Substituted carboxylic ceto-acids, process for the preparation thereof, use thereof and medicinal compositions containing them
DK0391185T3 (da) 1,8-Naphthyridiner
DE3484606D1 (en) Deodorant.
AU1243392A (en) Prostacycline and carbacycline derivatives as agents for treating feverish complaints
IE893157L (en) Stable oxapenem-3-carboxylic acids and their use as¹ß-lactamase inhibitors
BR9205351A (pt) Composição líquida contendo éster carboxílico complexo.
ES485992A1 (es) Procedimiento para la obtencion de un fungicida a base de carboximidas y derivados sulfamidicos
DE3824939A1 (de) Neue 2,2-dihalogencyclopropylhydroxyethyltriazole enthaltende antimykotische mittel
HUT62447A (en) Composition disinfecting and indicating body paris
ZA924925B (en) The use of organic compounds in dermatological compositions
ZA926126B (en) N-alcyl-n-heterocyclylalkylamino acids,processes,compositions and use
HU9801273D0 (en) Acylamino-alkyliden-hydroxy-bisphosphonic acids and pharmaceutical compositions containing the same
ES1023371Y (es) Contenedor involcable de doble uso perfeccionado.